Electromed (NYSE:ELMD) Raised to "Strong-Buy" at Roth Capital

Electromed (NYSE:ELMD - Get Free Report) was upgraded by research analysts at Roth Capital to a "strong-buy" rating in a research note issued on Monday,Zacks.com reports. Roth Capital also issued estimates for Electromed's Q4 2025 earnings at $0.22 EPS, FY2025 earnings at $0.81 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.31 EPS, Q3 2026 earnings at $0.21 EPS, Q4 2026 earnings at $0.26 EPS, FY2026 earnings at $1.00 EPS and FY2027 earnings at $1.15 EPS.

Other equities research analysts have also issued research reports about the company. Wall Street Zen lowered Electromed from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 8th. B. Riley upgraded Electromed to a "strong-buy" rating in a research note on Thursday, May 15th.

Electromed Trading Up 1.0%

NYSE ELMD traded up $0.18 during mid-day trading on Monday, reaching $18.82. 30,244 shares of the company's stock traded hands, compared to its average volume of 87,323. Electromed has a 1-year low of $13.74 and a 1-year high of $35.56. The company has a fifty day simple moving average of $20.22 and a 200-day simple moving average of $24.45. The company has a market cap of $157.82 million, a price-to-earnings ratio of 25.09 and a beta of 0.41.

Institutional Trading of Electromed

Institutional investors and hedge funds have recently bought and sold shares of the company. Squarepoint Ops LLC boosted its stake in Electromed by 7.8% in the fourth quarter. Squarepoint Ops LLC now owns 11,366 shares of the company's stock valued at $336,000 after acquiring an additional 823 shares during the period. Aristides Capital LLC boosted its stake in Electromed by 4.7% in the fourth quarter. Aristides Capital LLC now owns 26,076 shares of the company's stock valued at $771,000 after acquiring an additional 1,159 shares during the period. Russell Investments Group Ltd. acquired a new position in Electromed in the fourth quarter valued at approximately $37,000. Quantbot Technologies LP boosted its stake in Electromed by 57.7% in the first quarter. Quantbot Technologies LP now owns 5,301 shares of the company's stock valued at $126,000 after acquiring an additional 1,939 shares during the period. Finally, State of Wyoming acquired a new position in Electromed in the first quarter valued at approximately $48,000. Institutional investors and hedge funds own 40.82% of the company's stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.